HIGGINS JOHN L
Insider CIK 1208906 · OABI Director · TECH Director · BCRX Director · LGNDD President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TECH BIO-TECHNE Corp | A Award | 2026-10-29 | 2026-11-02 | 2,750 | — | $0 | 80,004 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2026-09-28 | 2026-09-30 | 15,940 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | F Tax w/h | 2026-09-28 | 2026-09-30 | 5,562 | $72.51 | $403.3K | 77,254 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2026-09-28 | 2026-09-30 | 15,940 | — | $0 | 82,816 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2026-09-28 | 2026-09-30 | 15,940 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | F Tax w/h | 2026-09-28 | 2026-09-30 | 5,562 | $72.51 | $403.3K | 77,254 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2026-09-28 | 2026-09-30 | 15,940 | — | $0 | 82,816 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-06-17 | 2026-06-18 | 20,000 | — | $0 | 2,962,320 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-01-30 | 2026-01-30 | 13,172 | — | $0 | 20,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-01-30 | 2026-01-30 | 13,172 | — | $0 | 2,942,320 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-11-07 | 2025-11-10 | 41,038 | $1.38 | $56.6K | 2,929,148 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-11-06 | 2025-11-10 | 36,223 | $1.41 | $51.1K | 2,888,110 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2025-10-30 | 2025-11-03 | 3,777 | — | $0 | 3,777 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2025-10-30 | 2025-11-03 | 1,640 | — | $0 | 66,876 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2025-08-07 | 2025-08-11 | 5,040 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2025-08-07 | 2025-08-11 | 5,040 | $21.84 | $110.1K | 65,236 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 13,172 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 33,172 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-06-17 | 2025-06-18 | 20,000 | — | $0 | 2,851,887 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-05-12 | 2025-05-13 | 65,000 | $1.44 | $93.6K | 2,831,887 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2025-05-01 | 2025-05-05 | 12,000 | — | $0 | 5,040 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2025-05-01 | 2025-05-05 | 12,000 | $21.84 | $262.1K | 60,196 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-03-21 | 2025-03-21 | 4,000 | $2.28 | $9.1K | 2,766,887 | SEC↗ |
| OABI OmniAb, Inc. | P Buy | 2025-03-20 | 2025-03-20 | 125,750 | $2.35 | $295.5K | 2,762,887 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-01-30 | 2025-01-30 | 13,172 | — | $0 | 33,172 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-01-30 | 2025-01-30 | 13,172 | — | $0 | 2,637,137 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2024-10-24 | 2024-10-28 | 3,511 | — | $0 | 3,511 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2024-10-24 | 2024-10-28 | 1,462 | — | $0 | 48,196 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2024-09-12 | 2024-09-16 | 6,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | F Tax w/h | 2024-09-12 | 2024-09-16 | 1,874 | $73.20 | $137.2K | 46,734 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2024-09-12 | 2024-09-16 | 6,000 | $22.95 | $137.7K | 48,608 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2024-07-08 | 2024-07-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2024-07-08 | 2024-07-10 | 6,000 | $22.95 | $137.7K | 42,608 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 26,344 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 46,344 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-06-18 | 2024-06-21 | 20,000 | — | $0 | 2,623,965 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2024-05-14 | 2024-05-16 | 4,000 | — | $0 | 12,000 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2024-05-14 | 2024-05-16 | 4,000 | $22.95 | $91.8K | 40,608 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2024-05-14 | 2024-05-16 | 4,000 | $83.84 | $335.4K | 36,608 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-01-30 | 2024-01-31 | 13,173 | — | $0 | 46,344 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-01-30 | 2024-01-31 | 13,173 | — | $0 | 2,352,625 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2023-10-26 | 2023-10-30 | 3,937 | — | $0 | 3,937 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2023-10-26 | 2023-10-30 | 1,625 | — | $0 | 36,608 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 20,000 | — | $0 | 59,517 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-05-23 | 2023-05-25 | 9,000 | — | $0 | 1,362 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-05-23 | 2023-05-25 | 9,000 | $3.68 | $33.1K | 2,471,686 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2023-05-23 | 2023-05-25 | 9,000 | $4.05 | $36.5K | 2,462,686 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-05-19 | 2023-05-23 | 1,000 | — | $0 | 10,362 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2023-05-19 | 2023-05-23 | 1,000 | $4.05 | $4.0K | 2,462,686 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-05-19 | 2023-05-23 | 1,000 | $3.68 | $3.7K | 2,463,686 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 50,000 | — | $0 | 11,362 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-05-18 | 2023-05-19 | 50,000 | $3.68 | $184.0K | 2,512,686 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2023-05-18 | 2023-05-19 | 50,000 | $3.89 | $194.5K | 2,462,686 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2023-04-28 | 2023-05-02 | 16,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | F Tax w/h | 2023-04-28 | 2023-05-02 | 4,377 | $79.88 | $349.6K | 34,983 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2023-04-28 | 2023-05-02 | 16,000 | $21.85 | $349.6K | 39,360 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 142,020 | — | $0 | 142,020 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-30 | 2023-02-01 | 39,517 | — | $0 | 2,462,686 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-01-04 | 2023-06-27 | 57,803 | $3.23 | $186.7K | 2,339,452 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2022-12-28 | 2023-06-27 | 25,914 | $3.66 | $94.8K | 2,397,255 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-12-28 | 2022-12-30 | 5,289 | $66.29 | $350.6K | 417,695 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 92,932 | — | $0 | 92,932 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-12-16 | 2022-12-20 | 10,000 | $61.87 | $618.7K | 422,984 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2022-12-12 | 2022-12-14 | 20,000 | — | $0 | 20,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-12-12 | 2022-12-14 | 3,944 | $64.80 | $255.6K | 432,984 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2022-12-12 | 2022-12-14 | 20,000 | $12.78 | $255.6K | 436,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-11-30 | 2022-12-01 | 9,803 | $72.90 | $714.6K | 416,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2022-11-18 | 2022-11-21 | 10,000 | — | $0 | 40,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2022-11-18 | 2022-11-21 | 10,000 | $12.78 | $127.8K | 426,731 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-11-17 | 2022-11-21 | 10,000 | $78.32 | $783.2K | 416,731 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2022-11-02 | 2022-11-03 | 246,648 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2022-11-02 | 2022-11-03 | 246,648 | $2.52 | $621.6K | 2,423,169 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2024-04-23 | 2,427,861 | — | $0 | 2,603,965 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 107,506 | — | $0 | 107,506 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 260,646 | — | $0 | 260,646 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 250,843 | — | $0 | 250,843 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 177,194 | — | $0 | 177,194 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 186,843 | — | $0 | 186,843 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 232,136 | — | $0 | 232,136 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 232,971 | — | $0 | 232,971 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 400,808 | — | $0 | 400,808 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 61,362 | — | $0 | 61,362 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 246,648 | — | $0 | 246,648 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-11-01 | 2022-11-03 | 45,922 | — | $0 | 424,731 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 2,176,521 | — | $0 | 2,176,521 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2022-10-27 | 2022-10-31 | 865 | — | $0 | 865 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2022-10-27 | 2022-10-31 | 338 | — | $0 | 5,840 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-09-16 | 2022-09-16 | 3,000 | $89.35 | $268.1K | 364,180 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-09-16 | 2022-09-22 | 1,000 | $88.06 | $88.1K | 366,180 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2022-09-15 | 2022-09-16 | 2,000 | $90.00 | $180.0K | 367,180 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-08-11 | 2022-08-12 | 8 | $380.71 | $3.0K | 5,502 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-08-11 | 2022-08-12 | 504 | $385.47 | $194.3K | 5,510 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2022-08-10 | 2022-08-12 | 3,400 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-08-10 | 2022-08-12 | 900 | $373.99 | $336.6K | 7,106 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2022-08-10 | 2022-08-12 | 3,400 | $66.90 | $227.5K | 8,006 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-08-10 | 2022-08-12 | 992 | $380.15 | $377.1K | 6,014 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-08-10 | 2022-08-12 | 100 | $374.90 | $37.5K | 7,006 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2022-06-30 | 2022-07-06 | 164 | $75.84 | $12.4K | 369,180 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-14 | 20,423 | — | $0 | 369,016 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2022-06-08 | 2022-06-09 | 600 | — | $0 | 3,400 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2022-06-08 | 2022-06-09 | 600 | $66.90 | $40.1K | 5,206 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-06-08 | 2022-06-09 | 600 | $366.09 | $219.7K | 4,606 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2022-06-07 | 2022-06-09 | 1,000 | — | $0 | 4,000 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2022-06-07 | 2022-06-09 | 1,000 | $66.90 | $66.9K | 5,606 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2022-06-07 | 2022-06-09 | 1,000 | $364.31 | $364.3K | 4,606 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale deriv | 2022-05-10 | 2022-05-10 | 8,000 | $429159.38 | $3.43B | 57,616 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2022-05-09 | 2022-05-10 | 0 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2022-05-09 | 2022-05-10 | 8,000 | $21.92 | $175.4K | 348,593 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-05-05 | 2022-05-09 | 76,478 | — | $0 | 76,478 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,946 | $123.68 | $240.7K | 344,570 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 2,061 | $123.68 | $254.9K | 342,509 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 1,916 | $123.68 | $237.0K | 340,593 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 13,560 | — | $0 | 358,261 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 3,060 | $113.68 | $347.9K | 355,201 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 6,183 | $113.68 | $702.9K | 349,018 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 9,606 | — | $0 | 344,701 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-11-12 | 2021-11-12 | 3,000 | $160.50 | $481.5K | 335,095 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2021-10-28 | 2021-11-01 | 633 | — | $0 | 633 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2021-10-28 | 2021-11-01 | 194 | — | $0 | 4,606 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2021-06-30 | 2021-07-02 | 247 | $85.91 | $21.2K | 338,095 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 2,061 | $172.46 | $355.4K | 337,848 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 1,947 | $172.46 | $335.8K | 339,909 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 1,204 | $172.46 | $207.6K | 341,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-05 | 2021-02-09 | 54,666 | — | $0 | 14,334 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-05 | 2021-02-09 | 60,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-05 | 2021-02-09 | 2,970 | $203.03 | $603.0K | 343,060 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-05 | 2021-02-09 | 54,666 | $14.47 | $791.0K | 340,696 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-05 | 2021-02-09 | 54,666 | $203.40 | $11.12M | 286,030 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-05 | 2021-02-09 | 60,000 | $10.05 | $603.0K | 346,030 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-02-03 | 2021-02-05 | 25,113 | — | $0 | 25,113 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 12,608 | — | $0 | 286,030 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-01-27 | 2021-01-27 | 30,000 | — | $0 | 65,616 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-01-27 | 2021-01-27 | 40,000 | — | $0 | 69,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-01-27 | 2021-01-27 | 40,000 | $14.47 | $578.8K | 283,422 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-01-27 | 2021-01-27 | 40,000 | $182.00 | $7.28M | 243,422 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-01-27 | 2021-01-27 | 30,000 | $21.92 | $657.6K | 273,422 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-01-25 | 2021-01-27 | 50,000 | — | $0 | 109,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 9,607 | — | $0 | 248,018 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-01-25 | 2021-01-27 | 50,000 | $159.00 | $7.95M | 235,310 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 5,946 | — | $0 | 241,256 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 2,845 | $156.01 | $443.8K | 238,411 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-01-25 | 2021-01-27 | 50,000 | $14.47 | $723.5K | 285,310 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 4,596 | $156.01 | $717.0K | 243,422 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2020-12-31 | 2021-01-05 | 223 | $84.53 | $18.9K | 235,310 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-12-08 | 2020-12-09 | 14,657 | — | $0 | 60,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-12-08 | 2020-12-09 | 1,683 | $87.52 | $147.3K | 235,087 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-12-08 | 2020-12-09 | 14,657 | $10.05 | $147.3K | 236,770 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 20,000 | — | $0 | 74,657 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-11-09 | 2020-11-10 | 2,458 | $81.77 | $201.0K | 222,113 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-11-09 | 2020-11-10 | 20,000 | $10.05 | $201.0K | 224,571 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2020-11-06 | 2020-11-10 | 5,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2020-11-06 | 2020-11-10 | 450 | $299.84 | $134.9K | 7,512 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2020-11-06 | 2020-11-10 | 5,000 | $70.35 | $351.8K | 9,412 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2020-11-06 | 2020-11-10 | 1,450 | $298.98 | $433.5K | 7,962 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2020-11-06 | 2020-11-10 | 3,100 | $301.06 | $933.3K | 4,412 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2020-10-29 | 2020-11-02 | 1,507 | — | $0 | 1,507 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2020-10-29 | 2020-11-02 | 391 | — | $0 | 4,412 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-07-07 | 2020-07-09 | 1,777 | — | $0 | 54,421 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-07-07 | 2020-07-09 | 1,165 | — | $0 | 54,226 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-07-07 | 2020-07-09 | 1,373 | — | $0 | 93,627 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-07-07 | 2020-07-09 | 1,165 | $85.79 | $99.9K | 201,421 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-07-07 | 2020-07-09 | 1,373 | $74.42 | $102.2K | 204,571 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-07-07 | 2020-07-09 | 1,777 | $56.26 | $100.0K | 203,198 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 2,117 | $97.23 | $205.8K | 205,173 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 1,310 | $97.23 | $127.4K | 207,290 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 1,689 | $97.23 | $164.2K | 208,600 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2020-02-13 | 2020-02-18 | 48,125 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-02-13 | 2020-02-18 | 60,886 | — | $0 | 60,886 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-02-13 | 2020-02-18 | 13,559 | — | $0 | 210,289 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-13 | 2020-02-18 | 5,009 | $95.68 | $479.3K | 196,730 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2020-02-13 | 2020-02-18 | 48,125 | $9.96 | $479.3K | 201,739 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2020-02-12 | 2020-02-14 | 5,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2020-02-12 | 2020-02-14 | 5,000 | $61.46 | $307.3K | 9,021 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2020-02-12 | 2020-02-14 | 5,000 | $205.23 | $1.03M | 4,021 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 5,946 | — | $0 | 156,562 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 2,948 | $105.87 | $312.1K | 153,614 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 3,801 | $105.87 | $402.4K | 150,616 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 7,668 | — | $0 | 154,417 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2019-10-24 | 2019-10-28 | 2,011 | — | $0 | 2,011 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2019-10-24 | 2019-10-28 | 495 | — | $0 | 4,021 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy deriv | 2019-09-19 | 2019-09-23 | 0 | $841250.00 | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy deriv | 2019-09-19 | 2019-09-24 | 0 | $988468.75 | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-07-31 | 2019-07-31 | 1,850 | $95.45 | $176.6K | 146,749 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2019-06-04 | 2019-06-06 | 5,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2019-06-04 | 2019-06-06 | 5,000 | $203.67 | $1.02M | 3,526 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2019-06-04 | 2019-06-06 | 5,000 | $63.03 | $315.1K | 8,526 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-31 | 2019-05-31 | 1,000 | $108.20 | $108.2K | 144,899 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-14 | 2019-05-14 | 2,500 | $113.50 | $283.8K | 143,899 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-03-13 | 2019-03-15 | 2,500 | $114.29 | $285.7K | 141,399 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 1,689 | $120.86 | $204.1K | 135,292 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 1,918 | $120.86 | $231.8K | 136,981 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-02-15 | 2020-04-24 | 1,310 | $120.86 | $158.3K | 133,982 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-02-11 | 2019-02-13 | 58,596 | — | $0 | 58,596 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-02-11 | 2019-02-13 | 12,809 | — | $0 | 138,899 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 6,390 | — | $0 | 129,258 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 3,597 | $111.78 | $402.1K | 122,868 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 7,256 | — | $0 | 126,465 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-01-23 | 2019-01-25 | 3,168 | $111.78 | $354.1K | 126,090 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-01-10 | 2019-01-14 | 4,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-01-10 | 2019-01-14 | 29,790 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-01-10 | 2019-01-14 | 4,000 | $16.14 | $64.6K | 89,419 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-01-10 | 2019-01-14 | 29,790 | $16.14 | $480.8K | 119,209 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2018-10-25 | 2018-10-29 | 1,898 | — | $0 | 1,898 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2018-10-25 | 2018-10-29 | 514 | — | $0 | 3,526 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-30 | 2018-08-31 | 3,500 | $258.25 | $903.9K | 85,419 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise deriv | 2018-08-23 | 2018-08-27 | 10,000 | — | $0 | 0 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2018-08-23 | 2018-08-27 | 10,000 | $187.92 | $1.88M | 3,012 | SEC↗ |
| TECH BIO-TECHNE Corp | M Exercise | 2018-08-23 | 2018-08-27 | 10,000 | $61.08 | $610.8K | 13,012 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-17 | 2018-08-17 | 12,993 | — | $0 | 159,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-17 | 2018-08-17 | 12,993 | $243.00 | $3.16M | 88,919 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-17 | 2018-08-17 | 12,993 | $14.47 | $188.0K | 101,912 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-08-16 | 2018-08-17 | 3,007 | — | $0 | 171,993 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-08-16 | 2018-08-17 | 3,007 | $14.47 | $43.5K | 110,426 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-16 | 2018-08-17 | 21,507 | $241.33 | $5.19M | 88,919 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-05-15 | 2018-05-15 | 12,405 | — | $0 | 29,790 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-05-15 | 2018-05-15 | 12,405 | $179.97 | $2.23M | 107,419 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-05-15 | 2018-05-15 | 12,405 | $16.14 | $200.2K | 119,824 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-03-06 | 2018-03-06 | 2,982 | $165.87 | $494.6K | 107,419 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-06 | 2018-03-06 | 6,015 | — | $0 | 110,401 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-03-02 | 2018-03-06 | 41,392 | — | $0 | 41,392 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-02 | 2018-03-06 | 7,928 | — | $0 | 104,386 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,689 | $157.18 | $265.5K | 96,458 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-02-15 | 2018-02-16 | 9,000 | $157.03 | $1.41M | 102,700 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 2,635 | $157.18 | $414.2K | 100,065 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,918 | $157.18 | $301.5K | 98,147 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-01-24 | 2018-01-26 | 22,500 | $165.00 | $3.71M | 111,700 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-01-19 | 2018-01-22 | 16,249 | — | $0 | 42,195 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-01-19 | 2018-01-22 | 16,249 | $155.00 | $2.52M | 146,050 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-01-19 | 2018-01-22 | 11,850 | $151.92 | $1.80M | 134,200 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-01-19 | 2018-01-22 | 16,249 | $16.14 | $262.3K | 162,299 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-12-28 | 2017-12-29 | 5,199 | $138.66 | $720.9K | 146,050 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-12-28 | 2017-12-29 | 9,965 | — | $0 | 151,249 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-17 | 2017-11-20 | 2,258 | $140.34 | $316.9K | 141,284 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-16 | 2017-11-17 | 5,269 | $142.53 | $751.0K | 143,542 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2017-10-26 | 2017-10-30 | 3,125 | — | $0 | 3,125 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2017-10-26 | 2017-10-30 | 739 | — | $0 | 3,012 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-10-13 | 2017-10-17 | 11,384 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-10-13 | 2017-10-17 | 11,384 | $21.92 | $249.5K | 150,555 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-10-13 | 2017-10-17 | 1,744 | $143.04 | $249.5K | 148,811 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-09-05 | 2017-09-06 | 5,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-09-05 | 2017-09-06 | 5,000 | $130.00 | $650.0K | 139,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-09-05 | 2017-09-06 | 5,000 | $21.00 | $105.0K | 144,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-08-08 | 2017-08-10 | 5,483 | — | $0 | 5,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-08-08 | 2017-08-10 | 5,483 | $125.00 | $685.4K | 139,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-08-08 | 2017-08-10 | 5,483 | $21.00 | $115.1K | 144,654 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-06-21 | 2017-06-23 | 4,666 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-06-21 | 2017-06-23 | 4,666 | $120.00 | $559.9K | 139,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-06-21 | 2017-06-23 | 4,666 | $21.00 | $98.0K | 143,837 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-06-09 | 2017-06-09 | 12,000 | — | $0 | 10,483 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-06-09 | 2017-06-09 | 12,000 | $21.00 | $252.0K | 151,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-06-09 | 2017-06-09 | 12,000 | $114.87 | $1.38M | 139,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-03-20 | 2017-03-21 | 4,000 | $109.10 | $436.4K | 139,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2017-03-08 | 2017-03-10 | 15,675 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-03-08 | 2017-03-10 | 1,473 | $106.92 | $157.5K | 143,171 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2017-03-08 | 2017-03-10 | 15,675 | $10.05 | $157.5K | 144,644 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-03-08 | 2017-03-10 | 4,000 | $107.06 | $428.2K | 128,969 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-02-24 | 2017-02-28 | 43,646 | — | $0 | 43,646 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 9,168 | — | $0 | 127,528 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-24 | 2017-02-28 | 4,783 | $100.38 | $480.1K | 122,745 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 10,224 | — | $0 | 132,969 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-15 | 2017-02-28 | 2,019 | $104.28 | $210.5K | 118,360 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-02-15 | 2017-02-28 | 2,285 | $104.28 | $238.3K | 120,379 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2016-10-27 | 2016-10-31 | 3,985 | — | $0 | 3,985 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2016-10-27 | 2016-10-31 | 914 | — | $0 | 2,273 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-09-22 | 2016-09-23 | 3,000 | $117.34 | $352.0K | 122,664 | SEC↗ |
| TECH BIO-TECHNE Corp | S Sale | 2016-09-08 | 2016-09-12 | 1,700 | $109.83 | $186.7K | 1,359 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-03-08 | 2016-03-09 | 6,000 | — | $0 | 22,483 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-03-08 | 2016-03-09 | 6,000 | $21.00 | $126.0K | 125,664 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-03-07 | 2016-03-09 | 556 | $102.97 | $57.3K | 119,664 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-03-07 | 2016-03-09 | 10,277 | $102.44 | $1.05M | 120,220 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2016-02-15 | 2016-02-16 | 2,492 | $85.97 | $214.2K | 130,497 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-16 | 55,391 | — | $0 | 55,391 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-02-11 | 2016-02-16 | 11,611 | — | $0 | 132,989 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2015-10-29 | 2015-11-02 | 4,260 | — | $0 | 4,260 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2015-10-29 | 2015-11-02 | 1,059 | — | $0 | 3,059 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-08-06 | 2015-08-07 | 4,666 | $110.79 | $516.9K | 121,378 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-06-09 | 2015-06-11 | 500 | $95.06 | $47.5K | 126,044 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-06-09 | 2015-06-11 | 6,200 | $92.53 | $573.7K | 129,844 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-06-09 | 2015-06-11 | 3,300 | $93.21 | $307.6K | 126,544 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-02-10 | 2015-02-11 | 56,198 | $56.26 | $3.16M | 56,198 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-02-10 | 2015-02-11 | 15,945 | — | $0 | 136,044 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award deriv | 2014-10-30 | 2014-11-03 | 4,000 | — | $0 | 4,000 | SEC↗ |
| TECH BIO-TECHNE Corp | A Award | 2014-10-30 | 2014-11-03 | 1,000 | — | $0 | 2,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-08-15 | 2014-08-15 | 1,000 | $54.97 | $55.0K | 120,099 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 75,000 | $74.42 | $5.58M | 75,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 10,000 | $74.42 | $744.2K | 85,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 10,000 | $74.42 | $744.2K | 95,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 16,875 | — | $0 | 48,125 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 16,875 | $9.96 | $168.1K | 127,974 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-02-12 | 2014-02-14 | 8,000 | — | $0 | 119,099 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 16,875 | $75.00 | $1.27M | 111,099 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-01-21 | 2014-01-21 | 9,000 | $21.00 | $189.0K | 28,483 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-01-21 | 2014-01-21 | 9,000 | $21.00 | $189.0K | 111,099 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-01-16 | 2014-01-21 | 15,000 | $64.00 | $960.0K | 102,099 | SEC↗ |